NDC 24208-040-41 - Xipere
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24208-040
- Requested NDC
- 24208-040-41
- Package NDCs from labels
- 24208-040-41, 24208-040-40, 24208-040-02, 24208-040-01
- Manufacturer
- Bausch & Lomb Incorporated | Alcami Carolinas Corporation
- Effective date
- 2025-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xipere - Bausch & Lomb Incorporated | Alcami Carolinas Corporation | Bausch & Lomb Incorporated | Alcami Carolinas Corporation | 2025-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24208-040-01 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-01 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-02 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-41 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24208-040-40 | ML - Milliliter | 24208-040 | da6c08ed-251c-4030-bfaf-2d7e536d5c98 | 1 | 2023-01-09 |
| 24208-040-41 | ML - Milliliter | 24208-040 | 676b47a3-48f2-4885-932c-12f0b33f42bd | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H K679OBS311 |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H K679OBS311 |
| 4 Kids Cold and Mucus Nighttime | EUPHRASIA STRICTA,SILICON DIOXIDE, RUMEX CRISPUS ROOT, ANEMONE PULSATILLA, GOLDENSEAL, SODIUM CHLORIDE, PHOSPHORUS, ONION, BRYONIA ALBA ROOT, MATRICARIA CHAMOMILLA, ARABICA COFFEE BEAN, CALCIUM SULFIDE AND SULFUR | Hyland's Inc. | 6f7b2585-2f0e-5938-e053-2a91aa0aa9d1 | 2022-11-21 | Warnings | 451W47IQ8X |
| 4 Kids Complete Cold and Mucus | BRYONIA ALBA ROOT, EUPHRASIA STRICTA, CALCIUM SULFIDE, SODIUM CHLORIDE, PHOSPHORUS, ANEMONE PULSATILLA, RUMEX CRISPUS ROOT, AND SILICON DIOXIDE | Hyland's Inc. | ef39fe3d-a42d-4baa-9199-91f664feb432 | 2022-11-21 | Warnings | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Cosette Pharmaceuticals, Inc. | 5b3bcc75-608d-23fd-91a5-0806d5fe32f5 | 2022-11-18 | Adverse reactions | F446C597KA |
| Nasal Allergy | TRIAMCINOLONE ACETONIDE | H E B | faaa9219-2673-485e-bd84-71bdb23b3e47 | 2022-11-12 | Warnings | F446C597KA |
| Multiple Electrolytes pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | 84221110-b3f1-42f4-800c-ad1d3b330e9e | 2022-11-10 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X 660YQ98I10 4550K0SC9B |
| Multiple Electrolytes pH 5.5 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | cf1f5f15-d31d-4a02-8f7e-b289d5ad4b5c | 2022-11-10 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X 660YQ98I10 4550K0SC9B |
| Natrum Muriaticum | NATRUM MURIATICUM | Hahnemann Laboratories, INC. | ecf06f13-012c-212d-e053-2995a90a7198 | 2022-11-08 | 451W47IQ8X | |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | 14b238ab-904b-45dc-9eb9-a1074364e089 | 2022-11-07 | B22547B95K | |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Proficient Rx LP | 5bb59e27-c49a-4543-bdca-c2070e90e162 | 2022-11-01 | Warnings, Adverse reactions | F446C597KA |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | B22547B95K | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | B22547B95K | |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Nasal Allergy | TRIAMCINOLONE ACETONIDE | CVS Pharmacy | 8c236d9d-2dee-40fc-adac-9d17a5eace9e | 2022-10-24 | Warnings | F446C597KA |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 51da05ce-e3c4-4ef5-a845-dc869152e17f | 2022-10-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Potassium Chloride | POTASSIUM CHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 31e02249-7984-4b8f-9e37-2b79b708ac08 | 2022-10-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Zydus Lifesciences Limited | 099c3a36-f460-4191-80e5-0c4153a5c713 | 2022-10-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Eye wash | PURIFIED WATER | McKesson | bd089fde-24ba-4de5-e053-2995a90a39bb | 2022-10-18 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.